Clinical research for a cure tomorrow

Annual Report 2025

More than just a review.
The Swiss Cancer Institute’s 2025 Digital Annual Report.

Prof. Dr. med. Miklos Pless, President of the Board until 31 December 2025

“We managed to stabilise and enhance the SCI during a transitional phase.”

To the foreword by Prof. Dr. Miklos Pless

Vincent Gruntz, CEO

“We have redefined the role of the SCI in Switzerland’s clinical cancer research landscape.”

To the foreword by Vincent Gruntz

Prof. Dr. med. Viviane Hess, the new President of the Board

“The SCI is becoming more modern, flexible and agile. I would like to continue along this path.”

To the interview

Updates & Highlights

The SCI awards seven grants totalling CHF 210,000 to promising research trials.

60 years of clinical cancer research in Switzerland – the Swiss Cancer Institute celebrates its anniversary.

In 2026, the SCI aims to activate 15 to 20 new clinical cancer trials – a new record.

Silvia Schenker, member of the Board of the Swiss Cancer Institute since 2022

Departments

The Swiss Cancer Institute has been dedicated to clinical cancer research for decades. A review of the key developments in the departments during 2025.

Clinical Operations

Structures and processes are aligned with growing requirements.

Quality & Compliance

Reorganisation, guidelines and training programmes: the SCI is setting the course for the future.

Research

Indication-specific priorities were defined in consultation with the clinical community.

Human Ressources

Collaboration is characterised by curiosity, responsibility and appreciation.

Finance

The investment strategy is robust and meets current requirements.

Communication

The foundations for a clear positioning in Switzerland have been laid.

Research

The key developments of the past year and the outlook.

Research highlights

Pooled expertise for clinical innovation

Research group

Strategic focus and key priorities

Publications / Research findings

Facts & Figures

The key developments of the past year and the outlook.

150

Patients

15

Ongoing clinical trials

1

Scientific articles

Facts & Figures

Engagement

The key developments of the past year and the outlook.

Young Oncology Academy

Targeted support for young talent in clinical study development

More on this topic

Patient Advisory Board

Patient council drives research: early input, 18 studies reviewed 2025

More on this topic

Events

Events 2025: exchange, training and strong interdisciplinary networking

More on this topic

Philanthropy & Partnership

New fundraising initiatives strengthen partnerships and funding

More on this topic

Finance

Strong base drives growth and advances clinical cancer research